Siddique Mohammad Anwar, McRaven Michael D, Arif Muhammad Shoaib, Allen Edward J, McKee Charia, Honne Shravya, Sultana Tahmina, Kim Baek, Carias Ann M, Mamede João I, Hope Thomas J
Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, Illinois, USA.
mBio. 2025 Jun 30:e0104725. doi: 10.1128/mbio.01047-25.
The early events of the HIV-1 life cycle, such as reverse transcription, and capsid shedding commonly known as uncoating, are interdependent and tightly regulated, enabling HIV-1 to adapt to diverse host cells. Here, we explored how host cell dNTP pool size modulates the kinetics and dynamics of HIV-1 reverse transcription and uncoating. We optimized an easy-to-use tool to inhibit the ribonucleotide reductase (RNR) catalyzed pathway of dNTP biosynthesis in CHOpgsA-745, HeLa (TZMbl), and owl monkey kidney (OMK) cells. RNR inhibitor rapidly reduced the cellular dNTP pool size, thereby restricting HIV-1 infectivity in a dose-dependent manner. This restriction was reversible upon inhibitor removal, and nucleoside supplementation partially restored infection by enhancing salvage pathways. We find that RNR inhibition slows reverse transcription kinetics and delays the initiation of uncoating in both the capsid integrity and TRIM-CypA restriction assays. Besides, the depletion of intracellular dNTP pools by RNR inhibition leads to significant reductions in both early and late HIV-1 reverse transcription products, with late-stage inhibition comparable to that observed with Nevirapine treatment. To demonstrate the impact of RNR inhibitors on capsid shedding, rather than an off-target effect, we resumed the RNR inhibition-induced delayed initiation of uncoating by reintroducing external dNTPs. This induced recommencement of rapid core integrity loss demonstrating its interplay with the progression of reverse transcription. Therefore, by inhibiting the RNR-catalyzed pathway of dNTP biosynthesis, we have reduced the dNTP pool of the host cells to an extent that delays the kinetics and dynamics of HIV-1 early life events.
Cellular dNTP pool homeostasis is maintained by the interplay between the biosynthetic ( and salvage) pathways and hydrolyzing networks such as SAMHD1. Inhibiting pathway using RNR inhibitors reduces the host cell dNTP pool size, thereby restricting HIV-1 infectivity reversibly. Whereas the salvage pathways cannot rescue HIV-1 infectivity to the full extent without the pathway. This work correlates HIV-1 infectivity with the dynamic nature of dNTP turnover due to RNR small subunit switching between RRM2 & RRM2B and the action of SAMHD1. The observed modulation of HIV-1 reverse transcription and uncoating in response to RNR inhibition demonstrates the flexibility and adaptability of the virus to replicate in hostile internal cellular environments, which attempt to starve the virus of essential metabolites such as dNTPs. These findings provide insights into how RNR inhibition may impact subsequent steps, such as nuclear localization and integration, offering a foundation for future studies.
HIV-1生命周期的早期事件,如逆转录,以及通常称为脱壳的衣壳脱落,是相互依存且受到严格调控的,这使HIV-1能够适应多种宿主细胞。在此,我们探究了宿主细胞脱氧核苷酸三磷酸(dNTP)池大小如何调节HIV-1逆转录和脱壳的动力学及动态变化。我们优化了一种易于使用的工具,以抑制中国仓鼠卵巢细胞(CHOpgsA-745)、人宫颈癌细胞(HeLa,TZMbl)和夜猴肾细胞(OMK)中由核糖核苷酸还原酶(RNR)催化的dNTP生物合成途径。RNR抑制剂迅速降低细胞内dNTP池大小,从而以剂量依赖方式限制HIV-1感染性。去除抑制剂后这种限制是可逆的,核苷补充通过增强补救途径部分恢复了感染。我们发现,在衣壳完整性和TRIM-CypA限制试验中,RNR抑制减缓了逆转录动力学并延迟了脱壳起始。此外,RNR抑制导致细胞内dNTP池耗竭,使HIV-1早期和晚期逆转录产物均显著减少,晚期抑制与奈韦拉平治疗观察到的情况相当。为证明RNR抑制剂对衣壳脱落的影响,而非脱靶效应,我们通过重新引入外部dNTP恢复了RNR抑制诱导的脱壳延迟起始。这诱导了快速的核心完整性丧失重新开始,证明其与逆转录进程的相互作用。因此,通过抑制RNR催化的dNTP生物合成途径,我们将宿主细胞的dNTP池减少到一定程度,从而延迟了HIV-1早期生命事件的动力学及动态变化。
细胞dNTP池稳态通过生物合成(和补救)途径与水解网络(如SAMHD1)之间的相互作用得以维持。使用RNR抑制剂抑制生物合成途径会降低宿主细胞dNTP池大小,从而可逆地限制HIV-1感染性。而没有生物合成途径时,补救途径无法完全挽救HIV-1感染性。这项工作将HIV-1感染性与由于RNR小亚基在RRM2和RRM2B之间切换以及SAMHD1的作用导致的dNTP周转动态性质相关联。观察到的RNR抑制对HIV-1逆转录和脱壳的调节表明,病毒在试图使其缺乏dNTP等必需代谢物的恶劣细胞内环境中复制时具有灵活性和适应性。这些发现为RNR抑制可能如何影响后续步骤(如核定位和整合)提供了见解,为未来研究奠定了基础。